EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Hypothyroidism in Older Adults: A Concise Review of the Recent Literature

Kamal Abouglila, Syed Fahim Mukhtar, Issam M. Hajjaji, Shehla Sheikh, Salem A. Beshyah

Journal of Diabetes and Endocrine Practice · 01.07.2024 · 07 (03) · 118-128

DOI: 10.1055/s-0044-1788596 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Diabetes and Endocrine Practice, erschienen am 01.07.2024. Verfasst von Kamal Abouglila und 4 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Hypothyroidism (HypoT) is a common condition whose prevalence varies according to regional and ethnic factors, dietary iodine, gender, and age. The symptoms of HypoT are generally nonspecific, with considerable overlap with other conditions. These symptoms are not useful for diagnosing HypoT, and a thyroid function test is required for a final diagnosis. Materials and methods We aimed to provide an overview of the recent global literature on HypoT in older adults. A narrative, nonsystematic review of the international literature from a single major medical online database (PubMed) for the past 5 years was performed. The relevant literature was narrated in a concise thematic account.

Results

Most studies and expert opinions reiterated the benefit of replacement therapy in younger and middle-aged individuals. A good volume of literature also considered the interplay between thyroid hormones and (1) cardiovascular function and risk factors, (2) cognitive function, (3) mental health, and (4) quality of life. Most workers are cognizant of the important difference in normal ranges of thyroid-stimulating hormone (TSH) and the consequent TSH targets in older adults compared to younger age groups. Extra care is recommended for the initiation and titration of thyroid hormone replacement therapy to avoid cardiovascular and skeletal adverse effects of relative overtreatment.

Conclusion

While clinical benefit is evident in patients under age 65 with overt and subclinical HypoT who are treated with levothyroxine, treatment may be harmful in older adults with subclinical HypoT. The 97th percentile of TSH distribution is 7.5 mIU/L for patients over age 80. Hence, TSH goals should be individualized in older adults to achieve any possible benefit and avoid unnecessary harm.

Zitieren

APA

Abouglila, K., Mukhtar, S. F., Hajjaji, I. M., Sheikh, S., & Beshyah, S. A. (2024). Hypothyroidism in Older Adults: A Concise Review of the Recent Literature. Journal of Diabetes and Endocrine Practice, 07(03), 118-128. https://doi.org/10.1055/s-0044-1788596

Vancouver

Abouglila K, Mukhtar SF, Hajjaji IM, Sheikh S, Beshyah SA. Hypothyroidism in Older Adults: A Concise Review of the Recent Literature. Journal of Diabetes and Endocrine Practice. 2024;07(03):118-128. doi:10.1055/s-0044-1788596

BibTeX
@article{Abouglila2024,
  author = {Abouglila, Kamal and Mukhtar, Syed Fahim and Hajjaji, Issam M. and Sheikh, Shehla and Beshyah, Salem A.},
  title = {Hypothyroidism in Older Adults: A Concise Review of the Recent Literature},
  journal = {Journal of Diabetes and Endocrine Practice},
  year = {2024},
  volume = {07},
  number = {03},
  pages = {118--128},
  doi = {10.1055/s-0044-1788596}
}
Kostenlos starten →